Abstract
PCR amplification of the regions containing the internally transcribed spacers and 5.8S rRNA gene of Candida krusei, C. inconspicua, and C. norvegensis yielded fragments of 510, 460, and 500 bp, respectively. HhaI digestion of these fragments yielded species-specific bands. Random amplification of polymorphic DNA with primer R108 showed interspecific discriminatory band patterns. Susceptibilities to fluconazole and amphotericin B were determined.
Full Text
The Full Text of this article is available as a PDF (1.8 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aufauvre-Brown A., Cohen J., Holden D. W. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J Clin Microbiol. 1992 Nov;30(11):2991–2993. doi: 10.1128/jcm.30.11.2991-2993.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baily G. G., Perry F. M., Denning D. W., Mandal B. K. Fluconazole-resistant candidosis in an HIV cohort. AIDS. 1994 Jun;8(6):787–792. doi: 10.1097/00002030-199406000-00010. [DOI] [PubMed] [Google Scholar]
- Botelho A. R., Planta R. J. Specific identification of Candida albicans by hybridization with oligonucleotides derived from ribosomal DNA internal spacers. Yeast. 1994 Jun;10(6):709–717. doi: 10.1002/yea.320100603. [DOI] [PubMed] [Google Scholar]
- Dupont B., Denning D. W., Marriott D., Sugar A., Viviani M. A., Sirisanthana T. Mycoses in AIDS patients. J Med Vet Mycol. 1994;32 (Suppl 1):65–77. doi: 10.1080/02681219480000731. [DOI] [PubMed] [Google Scholar]
- Essayag S. M., Baily G. G., Denning D. W., Burnie J. P. Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int J Syst Bacteriol. 1996 Jan;46(1):35–40. doi: 10.1099/00207713-46-1-35. [DOI] [PubMed] [Google Scholar]
- Fujita S., Lasker B. A., Lott T. J., Reiss E., Morrison C. J. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol. 1995 Apr;33(4):962–967. doi: 10.1128/jcm.33.4.962-967.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hazen K. C. New and emerging yeast pathogens. Clin Microbiol Rev. 1995 Oct;8(4):462–478. doi: 10.1128/cmr.8.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson E. M., Warnock D. W., Luker J., Porter S. R., Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother. 1995 Jan;35(1):103–114. doi: 10.1093/jac/35.1.103. [DOI] [PubMed] [Google Scholar]
- Kunová A., Trupl J., Dluholucký S., Galová G., Krcméry V., Jr Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species. Clin Infect Dis. 1995 Jul;21(1):226–227. doi: 10.1093/clinids/21.1.226. [DOI] [PubMed] [Google Scholar]
- Maiwald M., Kappe R., Sonntag H. G. Rapid presumptive identification of medically relevant yeasts to the species level by polymerase chain reaction and restriction enzyme analysis. J Med Vet Mycol. 1994;32(2):115–122. doi: 10.1080/02681219480000161. [DOI] [PubMed] [Google Scholar]
- Niesters H. G., Goessens W. H., Meis J. F., Quint W. G. Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol. 1993 Apr;31(4):904–910. doi: 10.1128/jcm.31.4.904-910.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pfaller M. A. Epidemiology of candidiasis. J Hosp Infect. 1995 Jun;30 (Suppl):329–338. doi: 10.1016/0195-6701(95)90036-5. [DOI] [PubMed] [Google Scholar]
- Polanco A. M., Rodríguez-Tudela J. L., Martínez-Suárez J. V. Detection of pathogenic fungi in human blood by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):618–621. doi: 10.1007/BF01690738. [DOI] [PubMed] [Google Scholar]
- Rex J. H., Cooper C. R., Jr, Merz W. G., Galgiani J. N., Anaissie E. J. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother. 1995 Apr;39(4):906–909. doi: 10.1128/aac.39.4.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Samaranayake Y. H., Samaranayake L. P. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol. 1994 Nov;41(5):295–310. doi: 10.1099/00222615-41-5-295. [DOI] [PubMed] [Google Scholar]
- Sandhu G. S., Kline B. C., Stockman L., Roberts G. D. Molecular probes for diagnosis of fungal infections. J Clin Microbiol. 1995 Nov;33(11):2913–2919. doi: 10.1128/jcm.33.11.2913-2919.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sullivan D. J., Westerneng T. J., Haynes K. A., Bennett D. E., Coleman D. C. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995 Jul;141(Pt 7):1507–1521. doi: 10.1099/13500872-141-7-1507. [DOI] [PubMed] [Google Scholar]
- Wardle H. M., Law D., Moore C. B., Mason C., Denning D. W. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrob Agents Chemother. 1995 Apr;39(4):868–871. doi: 10.1128/aac.39.4.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams D. W., Wilson M. J., Lewis M. A., Potts A. J. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol. 1995 Sep;33(9):2476–2479. doi: 10.1128/jcm.33.9.2476-2479.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]